Immutep Ltd Announces Cessation of Performance Rights

TipRanksDec 17 01:38 ET

Immutep's Phase 1 Trial Shows Favorable Safety Profile of Drug Candidate for Autoimmune Disease; Shares Down 3%

MT NewswiresDec 16 20:35 ET

Immutep Dips as Safety Test for Flagship Drug IMP761 Shows No Adverse Effects

The Market HeraldDec 16 18:27 ET

Immutep Ltd Reveals Key LAG-3 Binding Discovery

TipRanksDec 16 02:55 ET

Immutep Says Phase 2B Trial of Head, Neck Cancer Combination Therapy Shows 'Strong' Overall Survival; Shares Up 3%

MT NewswiresDec 11 22:38 ET

ASX 300 Healthcare Stock Lifts off on Promising New Results

The Motley FoolDec 11 19:38 ET